+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death



Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death



American Heart Journal 109(5 Pt 1): 949-958



The antiarrhythmic and antifibrillatory actions of the dextrorotatory isomer of sotalol, administered in a multiple-dose regimen, were evaluated in conscious dogs 3 to 5 days after anterior myocardial infarction. The intravenous administration of d-sotalol, four 8 mg/kg doses over a 24-hour treatment period, suppressed the induction of ventricular tachycardia by programmed electrical stimulation in six of nine dogs tested, slowed the rate of the induced tachyarrhythmia in two of the remaining three dogs, and provided significant protection (5 of 8 d-sotalol vs 0 of 8 vehicle control) against the development of ventricular fibrillation in response to ischemia at a site distant to a previous myocardial infarction. Increases in ventricular myocardial refractoriness and in QTc and paced QT intervals suggest that class III electrophysiologic actions contribute to the antiarrhythmic properties of dextrorotatory sotalol in this animal model. The degree of beta-adrenergic receptor blockade produced by d-sotalol in this dose regimen was negligible. These findings suggest the potential utility of d-sotalol in the prevention of ventricular tachycardia and ventricular fibrillation in the setting of myocardial infarction, particularly when beta-adrenergic receptor blockade is undesirable or contraindicated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041061490

Download citation: RISBibTeXText

PMID: 3993529

DOI: 10.1016/0002-8703(85)90234-0


Related references

Prevention of ventricular fibrillation by dextro sotalol in a conscious canine model of sudden coronary death. American Heart Journal 109(5 PART 1): 949-958, 1985

Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. American Heart Association Monograph (82): IV-125, 1981

Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. American Heart Journal 105(5): 711-717, 1983

Ventricular fibrillation in a conscious canine model of sudden coronary death prevention by chronic amiodarone therapy. American Heart Association Monograph: I-132, 1982

Prostacyclin on ventricular fibrillation in a conscious canine model of sudden coronary death. Naunyn-Schmiedeberg's Archives of Pharmacology 321(SUPPL): R54, 1982

Effect of flecainide acetate on ventricular tachycardia induction and ventricular fibrillation prevention in a conscious canine model of sudden death. Journal of the American College of Cardiology 7(2 SUPPL A): 84A, 1986

Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration. Circulation 68(4): 857-864, 1983

Ventricular fibrillation resulting from ischemia at a distant site in conscious canine model of sudden coronary death. American Heart Association Monograph (82): IV-218, 1981

Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death. Pharmacology 37(3): 171-186, 1988

Failure of Thromboxane Synthetase Inhibition to Protect the Postinfarcted Heart against the Induction of Ventricular Tachycardia and Ventricular Fibrillation in a Conscious Canine Model of Sudden Coronary Death. Pharmacology 37(3): 171-186, 1988

Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. American Journal of Cardiology 50(6): 1414-1423, 1982

Protection from ventricular fibrillation by um 272 2 hydroxy n n dimethyl n 1 methylethyl 3 1 naphthalenyloxy 1 propanaminium iodide in a conscious canine model of sudden coronary death. Federation Proceedings 41(5): ABSTRACT 8433, 1982

Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period evaluation in a conscious canine model of sudden death. Journal of the American College of Cardiology 9(2): 359-365, 1987

Ventricular fibrillation in conscious canine preparation of sudden coronary death prevention by short term and long term amiodarone administration. Circulation 68(4): 857-864, 1983

Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death. Journal of Cardiovascular Pharmacology and Therapeutics 1(4): 313-324, 1996